DE69625616T3 - Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung - Google Patents

Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung Download PDF

Info

Publication number
DE69625616T3
DE69625616T3 DE69625616T DE69625616T DE69625616T3 DE 69625616 T3 DE69625616 T3 DE 69625616T3 DE 69625616 T DE69625616 T DE 69625616T DE 69625616 T DE69625616 T DE 69625616T DE 69625616 T3 DE69625616 T3 DE 69625616T3
Authority
DE
Germany
Prior art keywords
oil
fish
lipid emulsion
fatty acids
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69625616T
Other languages
German (de)
English (en)
Other versions
DE69625616T2 (de
DE69625616D1 (de
Inventor
German Pscherer
Marco Junginger
Jörg Nehne
A. Yvon Carpentier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
B Braun Melsungen AG
Original Assignee
B Braun Melsungen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7778601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69625616(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by B Braun Melsungen AG filed Critical B Braun Melsungen AG
Priority to DE69625616T priority Critical patent/DE69625616T3/de
Publication of DE69625616D1 publication Critical patent/DE69625616D1/de
Publication of DE69625616T2 publication Critical patent/DE69625616T2/de
Application granted granted Critical
Publication of DE69625616T3 publication Critical patent/DE69625616T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69625616T 1995-11-28 1996-11-23 Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung Expired - Lifetime DE69625616T3 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE69625616T DE69625616T3 (de) 1995-11-28 1996-11-23 Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19544310 1995-11-28
DE19544310 1995-11-28
DE69625616T DE69625616T3 (de) 1995-11-28 1996-11-23 Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung
PCT/EP1996/005184 WO1997019683A1 (en) 1995-11-28 1996-11-23 Hydrolysis-optimized lipid emulsions and use thereof

Publications (3)

Publication Number Publication Date
DE69625616D1 DE69625616D1 (de) 2003-02-06
DE69625616T2 DE69625616T2 (de) 2003-11-06
DE69625616T3 true DE69625616T3 (de) 2010-07-08

Family

ID=7778601

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69625616T Expired - Lifetime DE69625616T3 (de) 1995-11-28 1996-11-23 Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung
DE19648566A Withdrawn DE19648566A1 (de) 1995-11-28 1996-11-23 Hydrolyseoptimierte Lipidemulsionen und ihre Verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19648566A Withdrawn DE19648566A1 (de) 1995-11-28 1996-11-23 Hydrolyseoptimierte Lipidemulsionen und ihre Verwendung

Country Status (15)

Country Link
US (1) US6008248A (enExample)
EP (1) EP0863754B2 (enExample)
JP (1) JP4165904B2 (enExample)
CN (1) CN1259908C (enExample)
AT (1) ATE230262T1 (enExample)
AU (1) AU701736B2 (enExample)
BR (1) BR9611826A (enExample)
CA (1) CA2236422C (enExample)
CZ (1) CZ161898A3 (enExample)
DE (2) DE69625616T3 (enExample)
ES (1) ES2189891T5 (enExample)
MX (1) MX9804127A (enExample)
NZ (1) NZ322927A (enExample)
PL (1) PL186618B1 (enExample)
WO (1) WO1997019683A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090636A1 (en) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
US6946488B2 (en) * 2000-05-01 2005-09-20 The Iams Company Pet food composition for reducing inflammatory response in cats
EP1539104A4 (en) * 2000-12-29 2005-06-15 Univ Columbia USE OF IV EMULSIONS OF DIFFERENT TRIGLYCERIDE COMPOSITION, PARTICLE SIZE AND APOLIPOPROTEIN E FOR TARGETED TISSUE DELIVERY OF HYDROPHOBIC COMPOUNDS
EP1900364B1 (en) * 2001-04-18 2013-09-25 ProMetic BioSciences Inc. Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
EP1279400A1 (en) * 2001-07-25 2003-01-29 Target Hit sa Modifying the fatty acid composition of cell membranes of organs and tissues
US20030032674A1 (en) * 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
AU2002350353A1 (en) * 2001-12-27 2003-07-15 Genesis Group Inc. Seal oil based lipid emulsions and uses thereof
CA2496923A1 (en) * 2002-08-29 2004-03-11 University Of Massachusetts Utilization of emulsion interface engineering to produce oxidatively stable lipid delivery systems
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
EP2560633B8 (en) 2010-04-23 2020-08-12 The Government of the United States, as represented by The Secretary of the Army Intravenous omega-3 fatty acid compositions & method of use
CN106241871A (zh) * 2016-07-15 2016-12-21 攀钢集团攀枝花钢铁研究院有限公司 高浓度钒液酸性铵盐沉钒方法
CN117918525A (zh) 2017-08-10 2024-04-26 儿童医疗中心有限公司 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物
CN108498562B (zh) * 2018-04-08 2021-03-16 北京壹诺药业有限公司 具有抗疲劳抗肿瘤增强免疫的油脂乳状液及其应用
US20220040141A1 (en) * 2018-10-01 2022-02-10 Blue Harvest, Llc Ultrapure phenol compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3722540A1 (de) * 1987-07-08 1989-01-19 Fresenius Ag Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung
FR2618332B1 (fr) * 1987-07-23 1990-04-27 Synthelabo Emulsion lipidique destinee a la nutrition parenterale ou enterale
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5574065A (en) † 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response

Also Published As

Publication number Publication date
AU701736B2 (en) 1999-02-04
CN1259908C (zh) 2006-06-21
ES2189891T3 (es) 2003-07-16
PL326929A1 (en) 1998-11-09
ATE230262T1 (de) 2003-01-15
DE69625616T2 (de) 2003-11-06
EP0863754B2 (en) 2009-12-30
JP4165904B2 (ja) 2008-10-15
BR9611826A (pt) 1999-07-13
DE69625616D1 (de) 2003-02-06
NZ322927A (en) 1999-06-29
EP0863754B1 (en) 2003-01-02
EP0863754A1 (en) 1998-09-16
CN1202823A (zh) 1998-12-23
CZ161898A3 (cs) 1998-11-11
US6008248A (en) 1999-12-28
CA2236422C (en) 2002-11-19
AU7697296A (en) 1997-06-19
PL186618B1 (pl) 2004-02-27
MX9804127A (es) 1998-12-31
DE19648566A1 (de) 1997-06-05
CA2236422A1 (en) 1997-06-05
JP2000500769A (ja) 2000-01-25
ES2189891T5 (es) 2010-04-27
WO1997019683A1 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
DE69625616T3 (de) Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung
DE69232564T2 (de) Phospholipide
EP0456670B1 (de) Omega-3-fettsäurehaltige fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung
EP0607231B1 (de) Verwendung einer emulsion, zur herstellung eines arzneimittels zur i.v.-verabreichung zur behandlung von hauterkrankungen
DE3687347T2 (de) Schnellwirkende, intravenoese emulsionen von omega-3-fettsaeureestern.
DE60129134T2 (de) O/w emulsion
DE69823548T2 (de) Verwendung von mehrfach ungesättigten fettsäuren zur vorbeugung von nekrotizierender enterokolitis
DE3734147C2 (de) Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
DE3877595T2 (de) Haltbare waesserige emulsionen aus fluorkohlenwasserstoffen.
DE69328618T2 (de) Medikamente auf der Basis von Docosahexaensäure, als Plättchenaggregationshemmer und gegen cerebralen Mangel an Fettsäuren, und Verfahren zur Herstellung.
CH680789A5 (enExample)
EP1488785A1 (de) Ölemulsion zur postnatalen Hormonsubstitution
EP2355813B1 (de) Fettemulsion zur künstlichen ernährung von schwerkranken intensivpatienten
DE3721137A1 (de) Fettemulsion zur intravenoesen anwendung
EP0456764B1 (de) Omega-3-fettsäurenhaltige fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung
DE69526450T2 (de) Emulsion zur verabreichung eines sphingolipids und deren verwendung
EP0071995B1 (de) Fettemulsion für parenterale Ernährung
DE3884945T2 (de) Emulsion für parenterale verabreichung.
EP0651995B1 (de) Cyclosporin(e) enthaltende o/w Emulsion zur oralen Verabreichung
DE69005298T2 (de) Arznei-lipid-zusammensetzung für parenterale nahrung.
EP1147769A2 (de) Verwendung von mehrfach ungesättigten Fettsäuren, insbesondere Omega-3-Fettsäuren, zur Behandlung von Enuresis und Inkontinenz
HUP9903426A2 (hu) Optimalizált hidrolízisű lipid emulziók és ezek gyógyszerként történő alkalmazása

Legal Events

Date Code Title Description
8366 Restricted maintained after opposition proceedings